New Zealand Winegrowers are on Cloud Wine over proposed Government changes to alcohol laws.

They include allowing licensed premises to meet legal obligations by stocking zero-alcohol drinks.

Currently, licence holders must stock 'low alcohol' products containing no more than 2.5 percent alcohol. 

Chief executive Phillip Gregan says it's a common sense change.

"Frankly, I'm not sure that there are any wines less than 2.5 percent, they tend to be slightly higher than that, or just zero."

LISTEN ABOVE

New Zealand Winegrowers are on Cloud Wine over proposed Government changes to alcohol laws.
They include allowing licensed premises to meet legal obligations by stocking zero-alcohol drinks.
Currently, licence holders must stock 'low alcohol' products containing no more than 2.5 percent alcohol.&nbsp;
Chief executive Phillip Gregan says it's a common sense change.
"Frankly, I'm not sure that there are any wines less than 2.5 percent, they tend to be slightly higher than that, or just zero."
LISTEN ABOVE

With a straight down the middle approach, Heather du Plessis-Allan Drive on Newstalk ZB delivers the very latest news and views to New Zealanders as they wrap up their day.

Heather du Plessis-Allan Drive

Philip Gregan: New Zealand Winegrowers CEO on the Government's proposed changes to alcohol laws

https://api.omny.fm/orgs/7784f840-c291-422a-924b-ad9000bbad71/clips/25edd918-fb75-48e8-ac0e-b40f0041cb5f/transcript

The Iran war is prompting Qantas to scale back flights within Australia, but it's flying more to Paris and Rome.

The airline's scaling back domestic Qantas and Jetstar flights about 5 percent.

Qantas says fuel prices have more than doubled since late February, and remain highly volatile.

Australian correspondent Murray Olds says the airline's projected to make a loss amid the ongoing conflict - and business confidence has dropped. 

LISTEN ABOVE

The Iran war is prompting Qantas to scale back flights within Australia, but it's flying more to Paris and Rome.
The airline's scaling back domestic Qantas and Jetstar flights about 5 percent.
Qantas says fuel prices have more than doubled since late February, and remain highly volatile.
Australian correspondent Murray Olds says the airline's projected to make a loss amid the ongoing conflict - and business confidence has dropped.&nbsp;
LISTEN ABOVE

Murray Olds: Australian correspondent on Qantas scaling back flights amid Middle East conflict

https://api.omny.fm/orgs/7784f840-c291-422a-924b-ad9000bbad71/clips/64446b4f-ebc1-4775-b968-b42c00534877/transcript

Horses will be absent from Crusaders' match-day Super Rugby experiences at Christchurch's new stadium due to safety reasons.

Officials say limited space around the field means the six steeds would have struggled to avoid the playing surface, therefore compromising the condition of the turf and creating potential injury risks. 

Sportstalk host Elliott Smith explained further.

LISTEN ABOVE

Horses will be absent from Crusaders' match-day Super Rugby experiences at Christchurch's new stadium due to safety reasons.
Officials say limited space around the field means the six steeds would have struggled to avoid the playing surface, therefore compromising the condition of the turf and creating potential injury risks.&nbsp;
Sportstalk host Elliott Smith explained further.
LISTEN ABOVE

Elliott Smith: Sportstalk host on the Crusaders retiring the matchday horses at the new One NZ stadium

https://api.omny.fm/orgs/7784f840-c291-422a-924b-ad9000bbad71/clips/dedbdede-7130-40e3-8a0b-b42c00517e58/transcript

New Zealand scientists are developing a long-acting ketamine tablet, which could change therapeutic delivery of the drug.

They're aiming to create a tablet patients can take at home once or twice a week, for treatment-resistant depression.

The pill is now being pushed towards regulatory approval in the United States, to make it widely available.

Otago University professor, Paul Glue, says it's a big change from current ketamine therapy.

"If you're getting the injection, it's got to be done in a clinic. You're going to be off your face, you're going to be very sedated, very spaced out - your blood pressure can go up." 

LISTEN ABOVE

New Zealand scientists are developing a long-acting ketamine tablet, which could change therapeutic delivery of the drug.
They're aiming to create a tablet patients can take at home once or twice a week, for treatment-resistant depression.
The pill is now being pushed towards regulatory approval in the United States, to make it widely available.
Otago University professor, Paul Glue, says it's a big change from current ketamine therapy.
"If you're getting the injection, it's got to be done in a clinic. You're going to be off your face, you're going to be very sedated, very spaced out - your blood pressure can go up."&nbsp;
LISTEN ABOVE

Paul Glue: Otago University professor on the development of a long-acting ketamine tablet

https://api.omny.fm/orgs/7784f840-c291-422a-924b-ad9000bbad71/clips/d92c60bb-4dba-47e0-ad40-b42c004f108d/transcript

Philip Gregan: New Zealand Winegrowers CEO on the Government's proposed changes to alcohol laws

In 1 playlist(s)

Heather du Plessis-Allan Drive

Social links

Follow podcast

Recent clips